136 related articles for article (PubMed ID: 15713396)
1. Discovery and investigation of a novel class of thiophene-derived antagonists of the human glucagon receptor.
Duffy JL; Kirk BA; Konteatis Z; Campbell EL; Liang R; Brady EJ; Candelore MR; Ding VD; Jiang G; Liu F; Qureshi SA; Saperstein R; Szalkowski D; Tong S; Tota LM; Xie D; Yang X; Zafian P; Zheng S; Chapman KT; Zhang BB; Tata JR
Bioorg Med Chem Lett; 2005 Mar; 15(5):1401-5. PubMed ID: 15713396
[TBL] [Abstract][Full Text] [Related]
2. Discovery of cyclic guanidines as potent, orally active, human glucagon receptor antagonists.
Sinz C; Chang J; Lins AR; Brady E; Candelore M; Dallas-Yang Q; Ding V; Jiang G; Lin Z; Mock S; Qureshi S; Salituro G; Saperstein R; Shang J; Szalkowski D; Tota L; Vincent S; Wright M; Xu S; Yang X; Zhang B; Tata J; Kim R; Parmee E
Bioorg Med Chem Lett; 2011 Dec; 21(23):7131-6. PubMed ID: 22001094
[TBL] [Abstract][Full Text] [Related]
3. Direct observation (NMR) of the efficacy of glucagon receptor antagonists in murine liver expressing the human glucagon receptor.
Cohen SM; Duffy JL; Miller C; Kirk BA; Candelore MR; Ding VD; Kaczorowski G; Tota LM; Werrmann JG; Wright M; Parmee ER; Tata JR; Zhang BB
Bioorg Med Chem; 2006 Mar; 14(5):1506-17. PubMed ID: 16256355
[TBL] [Abstract][Full Text] [Related]
4. Discovery and structure-activity relationship of the first non-peptide competitive human glucagon receptor antagonists.
Madsen P; Knudsen LB; Wiberg FC; Carr RD
J Med Chem; 1998 Dec; 41(26):5150-7. PubMed ID: 9857085
[TBL] [Abstract][Full Text] [Related]
5. Discovery of N-aryl-2-acylindole human glucagon receptor antagonists.
Sinz C; Bittner A; Brady E; Candelore M; Dallas-Yang Q; Ding V; Jiang G; Lin Z; Qureshi S; Salituro G; Saperstein R; Shang J; Szalkowski D; Tota L; Vincent S; Wright M; Xu S; Yang X; Zhang B; Tata J; Kim R; Parmee ER
Bioorg Med Chem Lett; 2011 Dec; 21(23):7124-30. PubMed ID: 22030028
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel, potent, and orally active spiro-urea human glucagon receptor antagonists.
Shen DM; Zhang F; Brady EJ; Candelore MR; Dallas-Yang Q; Ding VD; Dragovic J; Feeney WP; Jiang G; McCann PE; Mock S; Qureshi SA; Saperstein R; Shen X; Tamvakopoulos C; Tong X; Tota LM; Wright MJ; Yang X; Zheng S; Chapman KT; Zhang BB; Tata JR; Parmee ER
Bioorg Med Chem Lett; 2005 Oct; 15(20):4564-9. PubMed ID: 16102966
[TBL] [Abstract][Full Text] [Related]
7. New beta-alanine derivatives are orally available glucagon receptor antagonists.
Lau J; Behrens C; Sidelmann UG; Knudsen LB; Lundt B; Sams C; Ynddal L; Brand CL; Pridal L; Ling A; Kiel D; Plewe M; Shi S; Madsen P
J Med Chem; 2007 Jan; 50(1):113-28. PubMed ID: 17201415
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel, potent, selective, and orally active human glucagon receptor antagonists containing a pyrazole core.
Shen DM; Brady EJ; Candelore MR; Dallas-Yang Q; Ding VD; Feeney WP; Jiang G; McCann ME; Mock S; Qureshi SA; Saperstein R; Shen X; Tong X; Tota LM; Wright MJ; Yang X; Zheng S; Chapman KT; Zhang BB; Tata JR; Parmee ER
Bioorg Med Chem Lett; 2011 Jan; 21(1):76-81. PubMed ID: 21147532
[TBL] [Abstract][Full Text] [Related]
9. Ago-allosteric modulators of human glucagon-like peptide 2 receptor.
Yamazaki K; Terauchi H; Iida D; Fukumoto H; Suzuki S; Kagaya T; Aoki M; Koyama K; Seiki T; Takase K; Watanabe M; Arai T; Tsukahara K; Nagakawa J
Bioorg Med Chem Lett; 2012 Oct; 22(19):6126-35. PubMed ID: 22944117
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of thieno[2,3-b]pyrroles as antagonists of the GnRH receptor.
Arnould JC; Delouvrié B; Boutron P; Dossetter AG; Foote KM; Hamon A; Hancox U; Harris CS; Hutton M; Lamorlette M; Matusiak Z
Bioorg Med Chem Lett; 2007 Dec; 17(23):6448-54. PubMed ID: 17937987
[TBL] [Abstract][Full Text] [Related]
11. A novel series of indazole-/indole-based glucagon receptor antagonists.
Lin S; Zhang F; Jiang G; Qureshi SA; Yang X; Chicchi GG; Tota L; Bansal A; Brady E; Trujillo M; Salituro G; Miller C; Tata JR; Zhang BB; Parmee ER
Bioorg Med Chem Lett; 2015 Oct; 25(19):4143-7. PubMed ID: 26303893
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationships of uracil derived human GnRH receptor antagonists: (R)-3-[2-(2-amino)phenethyl]-1-(2,6-difluorobenzyl)-6-methyluracils containing a substituted thiophene or thiazole at C-5.
Rowbottom MW; Tucci FC; Connors PJ; Gross TD; Zhu YF; Guo Z; Moorjani M; Acevedo O; Carter L; Sullivan SK; Xie Q; Fisher A; Struthers RS; Saunders J; Chen C
Bioorg Med Chem Lett; 2004 Oct; 14(19):4967-73. PubMed ID: 15341961
[TBL] [Abstract][Full Text] [Related]
13. Discovery of thiophene-containing biaryl amide derivatives as novel glucagon receptor antagonists.
Li J; Feng Y; Li H; Shu S; Dai A; Cai X; Wang J; Yang D; Ma D; Wang MW; Liu H
Chem Biol Drug Des; 2018 Jul; 92(1):1241-1254. PubMed ID: 29469980
[TBL] [Abstract][Full Text] [Related]
14. Discovery of potent, orally active benzimidazole glucagon receptor antagonists.
Kim RM; Chang J; Lins AR; Brady E; Candelore MR; Dallas-Yang Q; Ding V; Dragovic J; Iliff S; Jiang G; Mock S; Qureshi S; Saperstein R; Szalkowski D; Tamvakopoulos C; Tota L; Wright M; Yang X; Tata JR; Chapman K; Zhang BB; Parmee ER
Bioorg Med Chem Lett; 2008 Jul; 18(13):3701-5. PubMed ID: 18539028
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and structure activity relationships of indazole and indole derivatives as potent glucagon receptor antagonists.
Song F; Xu G; Gaul MD; Zhao B; Lu T; Zhang R; DesJarlais RL; DiLoreto K; Huebert N; Shook B; Rentzeperis D; Santulli R; Eckardt A; Demarest K
Bioorg Med Chem Lett; 2019 Aug; 29(15):1974-1980. PubMed ID: 31138472
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and structure-activity relationships of thieno[2,3-b]pyridin-4-one derivatives as a novel class of potent, orally active, non-peptide luteinizing hormone-releasing hormone receptor antagonists.
Imada T; Cho N; Imaeda T; Hayase Y; Sasaki S; Kasai S; Harada M; Matsumoto H; Endo S; Suzuki N; Furuya S
J Med Chem; 2006 Jun; 49(13):3809-25. PubMed ID: 16789738
[TBL] [Abstract][Full Text] [Related]
17. Discovery of furan-2-carbohydrazides as orally active glucagon receptor antagonists.
Hasegawa F; Niidome K; Migihashi C; Murata M; Negoro T; Matsumoto T; Kato K; Fujii A
Bioorg Med Chem Lett; 2014 Sep; 24(17):4266-70. PubMed ID: 25127101
[TBL] [Abstract][Full Text] [Related]
18. Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): an oral, direct factor Xa inhibitor.
Roehrig S; Straub A; Pohlmann J; Lampe T; Pernerstorfer J; Schlemmer KH; Reinemer P; Perzborn E
J Med Chem; 2005 Sep; 48(19):5900-8. PubMed ID: 16161994
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and structure-activity relationship of novel thiophene derivatives for beta-amyloid plaque imaging.
Chandra R; Kung MP; Kung HF
Bioorg Med Chem Lett; 2006 Mar; 16(5):1350-2. PubMed ID: 16325402
[TBL] [Abstract][Full Text] [Related]
20. Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonist.
Brotherton-Pleiss CE; Dillon MP; Ford AP; Gever JR; Carter DS; Gleason SK; Lin CJ; Moore AG; Thompson AW; Villa M; Zhai Y
Bioorg Med Chem Lett; 2010 Feb; 20(3):1031-6. PubMed ID: 20045645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
